Related Experiment Video
Updated: May 25, 2026
06:09
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches
Alexandros Briasoulis1, Dimitris Tousoulis, Emmanuel S Androulakis
11st Cardiology Department, Hippokration Hospital, Athens University Medical School, Greece.
Recent Patents on Cardiovascular Drug Discovery
|January 28, 2012
Summary
Endothelial dysfunction, marked by low nitric oxide (NO), drives atherosclerosis. Early detection and treatments like statins and antioxidants can restore endothelial function and repair blood vessels.
Area of Science:
- Cardiovascular Science
- Vascular Biology
- Pharmacology
Background:
- Endothelial dysfunction, characterized by reduced nitric oxide (NO) bioavailability, is a key factor in atherosclerosis development.
- Early detection of endothelial dysfunction is crucial for timely intervention and preventing disease progression.
Purpose of the Study:
- To review the pathophysiology of endothelial dysfunction.
- To discuss established and novel therapeutic strategies for endothelial repair.
- To explore recent patents related to endothelial dysfunction treatments.
Main Methods:
- Literature review of pathophysiological mechanisms.
- Analysis of pharmacological therapies including renin-angiotensin system inhibitors, statins, erythropoietin, tetrahydrobiopterin, and antioxidants.
- Review of recent patent literature on endothelial repair.
Main Results:
- Pharmacological therapies aim to boost NO synthase activity, increase NO release, inhibit NO degradation, and enhance endothelial progenitor cell activity.
- Established treatments and novel approaches are available for endothelial repair.
- Recent patents highlight ongoing innovation in the field.
Conclusions:
- Endothelial dysfunction is a critical target for atherosclerosis treatment.
- A range of therapeutic options exist to restore endothelial function.
- Continued research and patent activity indicate a dynamic field for cardiovascular health.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...